Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Standex International Corporation filings document the reporting obligations of a diversified industrial manufacturer with operations across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions. Form 8-K filings furnish quarterly results, segment performance commentary, order trends, portfolio actions, leverage updates, and exhibits tied to earnings releases.
The company’s proxy and governance filings cover director elections, advisory executive compensation votes, auditor ratification, board matters, and executive compensation disclosures. Other current reports record officer transitions and related management changes, providing formal disclosure on governance, leadership structure, financial reporting, and capital-allocation matters.
Standex International (SXI) disclosed a Form 4 indicating a director received 639 shares of common stock on 10/21/2025 as a restricted stock grant under the company’s 2018 Omnibus Incentive Plan.
The award was recorded at $0 per share and vests three years after the grant date. Following this transaction, the reporting person beneficially owns 6,285 shares, held directly.
Standex International (SXI) reported an insider equity award. A director received a grant of 639 shares of common stock on 10/21/2025, coded as an acquisition under the company’s 2018 Omnibus Incentive Plan. The grant price was $0, and the restricted stock is scheduled to vest three years after the grant date.
Following this grant, the reporting person beneficially owns 6,639 shares, held directly. This filing reflects routine director compensation in equity rather than an open‑market purchase or sale.
Standex International (SXI) director reported an equity grant. On 10/21/2025, the reporting person acquired 639 shares of common stock as a grant of restricted stock under the Company’s 2018 Omnibus Incentive Plan, vesting three years after the grant date. The filing lists the transaction price as $0, consistent with a stock grant. Following the grant, the filer beneficially owned 3,575 shares directly and 13,751 shares indirectly as trustee of a trust.
Standex International (SXI) reported a director’s Form 4 showing stock acquired through the vesting of phantom stock units tied to the director’s retirement. On 10/21/2025, the director acquired common stock via transaction code M in three lots: 663 shares at $106.10, 581 shares at $120.86, and 599 shares at $117.36. Following these transactions, the director beneficially owned 11,389.254 shares directly. The related phantom stock unit awards were converted, leaving 0 derivative securities beneficially owned after the reported transactions.
Standex International (SXI) reported insider transactions by an individual who is both a Director and the President/CEO/Chairman. On 10/15/2025, the insider reported two sales totaling 18,000 shares at $235 per share, executed pursuant to a Rule 10b5-1 trading plan dated November 22, 2024. The transactions were reported as indirect holdings in the capacity of Trustee of a Trust.
SXI: A Form 144 notice discloses a proposed sale of 18,000 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $4,230,000. The approximate sale date is October 15, 2025. The filing lists 12,068,262 shares outstanding.
The securities to be sold were acquired via RSU vests from the issuer on 09/06/2023 (13,000 shares) and 09/06/2022 (5,000 shares). Recent activity over the past three months includes sales by related trusts: 5,000 shares for $1,000,000 on 08/13/2025, and 11,000 shares for $2,200,000 on 08/13/2025, plus 11,000 shares for $2,365,000 on 09/18/2025. This notice outlines an intended sale under Rule 144 by the holder, separate from the company’s capital-raising activities.
Standex International Corp reporting person David A. Dunbar, who is listed as President/CEO/Chairman and Director, sold shares under an existing trading plan. The filing shows a sale of 11,000 shares of common stock on 09/18/2025 at a price of $215 per share, executed pursuant to a 10b5-1 plan dated November 22, 2024. After the reported transaction, the reporting person is shown as beneficially owning 121,973 shares indirectly. The form also references 1,429.9759 shares in connection with a trustee relationship. The form is signed by Alan J. Glass on 09/19/2025.
Standex International Corp reporting person David A. Dunbar, who is listed as President/CEO/Chairman and Director, sold shares under an existing trading plan. The filing shows a sale of 11,000 shares of common stock on 09/18/2025 at a price of $215 per share, executed pursuant to a 10b5-1 plan dated November 22, 2024. After the reported transaction, the reporting person is shown as beneficially owning 121,973 shares indirectly. The form also references 1,429.9759 shares in connection with a trustee relationship. The form is signed by Alan J. Glass on 09/19/2025.
Standex International Corp. (SXI) notice reports a proposed sale of 11,000 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $2,365,000 and approximately 12,068,262 shares outstanding. The shares were acquired on 09/06/2023 by vesting of restricted stock units (RSU vest) from the issuer. The filing also discloses related sales within the past three months: a sale of 5,000 shares for $1,000,000 and a sale of 11,000 shares for $2,200,000, both dated 08/13/2025. The filer certifies no undisclosed material adverse information and references the Rule 10b5-1 trading plan representation.
Standex International Corp. (SXI) notice reports a proposed sale of 11,000 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $2,365,000 and approximately 12,068,262 shares outstanding. The shares were acquired on 09/06/2023 by vesting of restricted stock units (RSU vest) from the issuer. The filing also discloses related sales within the past three months: a sale of 5,000 shares for $1,000,000 and a sale of 11,000 shares for $2,200,000, both dated 08/13/2025. The filer certifies no undisclosed material adverse information and references the Rule 10b5-1 trading plan representation.
Standex International Corporation is holding its 2025 Annual Meeting of Shareholders on October 21, 2025 at its Salem, New Hampshire headquarters. Shareholders of record as of August 26, 2025 can vote in person, by Internet, phone or mail on three proposals.
These proposals are the election of two Class III directors (Thomas E. Chorman and Andy L. Nemeth) for terms expiring in 2028, an advisory “Say on Pay” vote on executive compensation, and the ratification of Deloitte & Touche LLP as independent auditors for fiscal 2026.
The proxy highlights extensive governance practices, including a majority-independent board, fully independent key committees, a lead independent director, mandatory board retirement age, stock ownership guidelines, anti-hedging and anti-pledging policies, and ESG and cybersecurity oversight. Deloitte audit and related fees totaled $4,153,000 in FY 2025, and CEO David Dunbar’s total compensation was $5,117,281, with a large portion in equity and incentive pay tied to performance.
David A. Dunbar, identified as a director and as an officer with the title President/CEO/Chairman of Standex International Corp (SXI), reported transactions dated 09/03/2025 on a Form 4. The filing shows two non-derivative entries for Common Stock with transaction code J(1) and quantity 17,397 shares on each reported line. One line shows those shares as Disposed (D) at $0 with a following beneficial ownership figure shown as 1,429.9759 D in the table. The second line shows the same quantity as Acquired (A) at $0 with a following beneficial ownership figure shown as 132,973 I and the notation Trustee of Trust. The explanatory note states these transactions reflect shares gifted by the reporting person to a revocable trust for which he is Trustee.